Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
CHAPTER II
PURIFICATION AND CHARACTERIZATION OF
L -ALANINE:4,5-DIOXOVALERA TE TRANSAMINASE
FROM RAT LIVER MITOCHONDRIA
- 60 -
SU.fvlMARY
Rat liver mitochondria has been found to contain
L-alanine:4,5~dioxovalerate transaminase which catalyzes
the formation of S-aminolevulinic acid via a transamination
reaction. The enzyme alanine:DOVA transaminase was
purified to apparent homogeneity with a 422-fold and
20% yield.
The purification procedure included protamine sulfate,
and bentonite precipitation, hydrophobic chromatography
on phenyl sepharose, DEAE cellulose-DE52 chromatography
and gel filtration. The purified enzyme had a specific
_activity of 59.5 unit/mg protein, and appeared homogenous
by gel electrophoresis. The molecular weight of the
native enzyme was estimated to be 232,000 + 3000 by gel
filtration. Under denaturing conditions, the dissociated
enzyme had a single subunit of approximately
Mr 41,000 + 2000, indicating the enzyme apparently is
composed of six identical subunits. The enzyme was heat
stable and had optimal activity at pH 6.9. The enzyme
is observed to be specific for L-alanine and 4,5-dioxovalerate
as its substrates. The Km values for L-alanine and
4,5-dioxovalerate ~ere 3.3 mM and 0.28 mM respectively.
The enzyme bound pyridoxal phosphate content was
estimated to be 10.6 nmole of PLP/rng of purified protein.
- 61 -
Alanine:DOVA transaminase activity was inhibited
by the sulfhydryl inhibitors i.e. p-chloromercuri benzene
sulfonate, n-ethylmaleimide and Iodoacetate, the reaction
product pyruvic acid and substrate analogs oe.-ketoglutaric
acid and methylglyoxal. Excess concentrations of
4,5-dioxovalerate and pyridoxal phosphate were also
found to be the inhibitors of alanine:DOVA transaminase.
INTRODUCTION
In the previous chapter, it has already been shown
that in the mammalian system, ·L-alanine: 4, 5-dioxovalerate
transaminase is an important enzyme which catalyzes the
formation of aminolevulinic acid. Recent reports (21,142)
indicate the existence of alanine:DOVA transaminase in
bovine liver and suggest its important role on heme
biosynthesis. The capacity of alanine:DOVA transaminase
to synthesize S-aminolev~linic acid, the first committed
precursor of heme appears to be far greater than the
capacity of ALA synthetase from the same source. However,
little is known about the role of this enzyme on the
process of heme biosynthesis.
On the other hand, the known fact is that the rate
limiting step in the hepatic heme biosynthesis is
normally ¥>A synthetase, the first enzyme of the pathway
(15,65}. The level of this enzyme is app~rently regulated.
- 62 -
by the concentrations of intracellular heme, and in
normal liver this mitochondrial enzyme is maintained at
low level. While heme may regulate hemeprotein synthesis,
and it regulates its own synthesis (65,68),which is
brought about by end product regulation of ALA synthetase.
Thus, it is apparent that ALA formation in the mammalian
system either by ALA synthetase or via alanine:DOVA
transaminase reaction is highly crucial for controlling
heme biosynthesis. Since nothing is known about the
nature of alanine: DOVA transaminase, our aim is to study
the role of alanine:DOVA transaminase on the regulation
of heme biosynthesis. Our ultimate goal of this
programme is to isolate mRNA specific for alanine:DOVA
transaminase by raising antibody against it, which in turn
can be used to precipitate specifically the ~olysomes
synthesizing nascent chains of this enzyme. As a part
of this programme, it is of importance to purify and
characterize the enzyme. Thus, in this chapter, the
results of purification and characterization of
alanine:DOVA transaminase has been presented.
RESULTS
0 All purification procedures were carried out at 4 C
unless stated otherwise. The mitochondria were isolated
from the liver of 48 hr fasted male wistar rats weighing
175-200 g.
- 63 -
Step 1 Preparation of Mitochondrial Extract : Rats
were sacrificed by cervical dislocation, the livers were
collected and cut into very small pieces with scissors.
Then livers were.washed thrice with cold saline and homo
genized for 1 min in Waring blendor with 4 volumes of
0.25 M sucrose in 5 ~potassium phosphate buffer, pH 7.6.
The crude homogenate was centrifuged at 500 x g for 15 min
to sediment nuclei and debris. Then postnuclear fraction
was centrifuged at 10,000 x g for 10 min and the mito
chondria pellet was washed two times with the same buffer.
The packed mitochondria were suspended finally in an
equal volume of 5 mM potassium phosphate buffer _containing
10% glycerol and freeze-thawed and sonicated for 1 min at
10 Khz, and centrifuged at 10,000 x g for 30 min.. The
pellet was washed twice with 0.5 volume of the same buffer
and supernatants were pooled.
Step II : Fractionation with Protamine Sulfate To the
above 100 ml of enzyme preparation, 20 ml of 2% (w/v)
protamine sulphate was added with stirring at 4°C. After
being left for 20 min the precipitate was removed by
centrifugation for 10 min at 10,000 x g. The enzyme
activity and protein were assayed in the supernatant, and
specific activity of alanine:DOVA transaminase was
· determined in this fraction which was 0.226/mg protein.
(Table IV) •
TABLE IV
PURIFICATION OF L-ALANINE:4,5-DIOXOVALERATE TRANSAMINASE FROM RAT LIVER MITOCHONDRIA
-----------------~------------------------------------------------Alanine:4,5-dioxovalerate transaminase
Fraction number Protein Total Specific Purifi- Yield
Mitochondrial extract
Protamine sulpl1.ate
Bentonite
Phenyl Sepharose CL-4B
DEAE cellulose DE-52
Sepharose-6B
activity activity cation
mg unitsa unit/mg fold
195.24 27.6 0.141 1
99.37 22.68 0.228 1.6
35.75 18.48 0.516 3.7
2.11 15.34 7.270 51.3
0.259 6.38 24.63 174.7
0.094 5.6 59.5 421.9
%
100
82.1
70.0
55.5
23.1
20.2
---7--------------------------------------------------------------
aone unit is the amount of enzyme that will catalyse the formation of 1 p mol of 6-arninolevulinic acid/30 min at
. 37°C.
- 64 -
Step III : Fractionation with Bentonite : Bentonite was
added to the resulting supernatant to 1.25% saturation.
and stirred for 15 min. The precipitated proteins were
removed by centrifugation at 10,000 x g for 10 min. The
specific activity of. transarninse in the supernatant was
0.526/rng protein (Table IV).
Step IV : Phenyl Sepharose CL-4B Column Chromatography
The enzyme solution was then passed through phenyl
sepharose column (2.5 x 11 ern) using 5 rnM potassium
phosphate buffer, pH 7. 6, containing 10% glycerol. The
enzyme did not bind to the hydrophobic support and
was eluted in the buffer wash (Fig. 7) . Th~ fractions
with activity were pooled and it was observed that the
specific activity was 7.24 unit/rng protein with 51.3 fold
purification (Table IV) .
Step V : DEAE Cellulose DE-52 Chromatography : The sample
from the above was applied to a column of DEAE cellulose
(4 x 7.5 ern), which was equilibrated previously with the
same buffer. The column was washed with 150 rnl of
buffer, then enzyme was eluted with a linear gradient of
KCl going from 0 to 0.25 M in the same buffer at the
flow rate of 36 rnl/hr. The total volume of the gradient
was 500 rnl and the enzyme was eluted approximately in
the middle of the gradient (Fig. 8). The fractions with
Fig. 7 : CHROMATOGRAPHIC PROFILE OF ALANINE:
DOVA TRANSAMINASE ON PHENYL-SEPHAROSE:
The post-bentonite treated enzyme was
applied to a column (2.5 x 11 em), which
was equilibrated with 5 mM potassium
phosphate buffer, pH 7.6 containing 10%
glycerol. The enzyme was eluted in the
buffer washo •-. --•, protein; o~o,
alanine:DOVA transaminase activity.
0·30 1· 50 >-.,_;.--> 1-0·25 1·2 5 u <!
w l/)
I 1·00 <! z -~ <! E U)
c: 0·75 z
I 0 <! 0:: co I-N
<! o· so <! > 0 0
w 0·2 5 z
z <! _J
0 <! 0 20 40 60 80 100 120 14 0
ELUTION VOLUME,ml
i I
Fig. 8 DEAE cellulose DE-52 chromatography
of rat L-alanine:4,5-dioxovalerate
transaminase. The buffer wash from
the preceeding phenyl. sepharose
chromatographic step was applied to
a column (4 x 7.5 ern} of DEAE cellulose
DE-52. The column was washed with
150 rnl of buffer. The enzyme was eluted
using a linear gradient of 0-0.25 M KCl
(500 ml) in potassium phosphate buffer,
pH 7.6, containing 10% glycerol. Flow
rate, 36 rnl/hr. Fraction size, 4 rnl.
0
0.100 0.10 0 I "'"' I 0.075 E
0.075 -::> ->-
E t--
c >
~ 0.050 0.050 t-u
N <(
<( UJ 2 >-
'0.025 0.025 N z w
o--~~~--~~~~----~----~--~ 0 20 40 60 80 100 120
FRACTION NUMBER
- 65 -
highest activity were pooled in dialysis tube
(processed) and concentrated with polyethylene glycol
20,000. The procedure gave a purification fold of
175 and yield of 23% (Table IV).
Step VI : Sepharose 6B Gelfiltration Chromatography :
The concentrated alanine:DOVA transaminase preparation
was applied to a column (2.0 x 3.7 em) of sepharose-6B,
equilibrated with same buffer, and the flow rate was
maintained 16 ml/hr. The active fractions were pooled
and centrifuged. This procedure resulted in a purifica-
tion of approximately 422-fold with an overall recovery
of 20.2% (Table IV). '
Homogeneity
In polyacrylamide gel electrophoresis of the purified
transaminase fractions resulted only one defined band
showing the homogeneity of the enzyme (Fig. 9a). Moreover,
densitometric scanning of the gel also showed single peak
(Fig. 9b) .
Properties and Characterization of L-Alanine:4,5-Dioxo-
velerate Transaminase
Effect of enzyme concentration When transaminase
activity was plotted against enzyme concentrations, straight
line was obtained, indicating that the reaction rate of
Fig. 9a
Fig. 9b :.
Polyacrylamide disc gel electrophoresis
of the purified L-alanine:4,5-dioxo
valerate transaminase. The purified
enzyme preparation (protein 30 pg)
was subjected to electrophoresis at
pH 8.9 in 7% gel.
Densitometric scanning of the gel.
The purified enzyme preparation
(protein 50 Jlg) was subjected to
electrophoresis at pH 8.9 in 7% gel •
•
9a
... ·--
-- - _I
2·5 9b
2·0
E c 1-5
0
~
w u 1·0 z <{ CD 0::: 0 t/)
CD 0·5 <!
0 2 4 8
LENGTH(Cm)
- 66 -
the enzyme is directly proportional to enzyme concentra
tion (Fig. 10) .
Effect of time : The rate of reaction of alanine:DOVA
transaminase was linear with the time upto 90 mins
(Fig. 11) .
Effect of pH Fig. 12 shows the effect of pH on the
formation of ALA by alanine:DOVA transaminase. The
enzyme has optimal activity at pH 6.9 in 50 mM potassium
phosphate buffer, with a broad peak exhibiting 90% activity
at pH 6.3 and at 7.4. The enzyme was virtually inactive
when 0.1 M Tris HCl was used as the assay buffer.
Substrate specificity studies : The specificity of the
alanine:DOVA transaminase with regard to the amino donor
was examined by replacing alanine with other amino
donors (Table V). The enzyme is specific for alanine and
is sterospecific for L-isomer. Studies on the specificity
of amino acceptor- other than OOVA were technically .
difficult because the product of transamination was not
ALA.
Effect of substrate concentration : The rate of reaction
was determined with varying concentration of one substrate
at a time keeping the other constant. As shown in
Fig. 13a and l3b, the Km values were determined
Fig. 10 Relationship between alanine:
4,5-dioxovalerate transaminase
activity and amount of protein
used (purified enzyme) •
:r ·( ">-
.!.:.) t-
~- ... > 60 ...,:: ' t-
(_)
<{
w 50 tf)
<{ ,-...
z c 2 E 40 <{ U)O
z (Y')
<{ ' . - 30 0:: 0 t-
E <{ c >- 20 0 0
w z 10 --z· <{ __J
<{ 0 0 2 3 4 5 6
ALANINE DOVA TRANSAMIN-ASE. CONCENTRATION ()Jg)
Fig. 11 Relationship between alanine:
4, 5.-dioxovalerate transaminase
activity and duration of
incubation. Fixed amount of
enzyme was used for each assay.
>- 3 0 t-
> t-
~ ~25 ClJ w .......
Lf) 0 ~
~ 0.20 - en ~ E <( lf)........_
z -15 <( 0
a: E t-:J:.. <( '-"'1 0 > 0 0
w z z <( _J
5
<( 0~--~--~--~----~--~--~--~~--+---~--~ 0 20 40 60 80 10 0
TIME (min)
Fig. 12 Effect of pH: L-alanine:
4,5-dioxovalerate transaminase
activity was determined as
described under experimental
procedures, over the pH range
from 6 • 3 to 7 • 9 •
,....... c
18 ·-C1J -0 L a. 0'1 16 E -:::> ->-t- 14 -> t-u <( 12 w 2 >-N z 10 w
01' 6 7 8
pH
TABLE V
COMPARISON OF AMINODONORS FOR L-ALANINE:4,5-DIOXOVALERATE TRANSAMINASE*
Amino donor % of enzyme activity
L-Alanine 100
DL-Alanine 59.8
D-Alanine 0
Arginine 0
L-glutamic acid 0
Glycine 2.3
Phenylalanine 12.6
*The enzyme was assay.ed under standard conditions. The concentration of all amino donors was 20 mM.
- 67 -
by plating Lineweaver Burk plots (1/v against 1/substrate)
according to the method of Dixon and Webb (173). The
enzyme demonstrated Michaelis-Menton kinetics for both
substrates. The apparent Km value for L~alanine was 3.3 mM
and the apparent Km for 4,5-dioxovaleric acid was 0.28 mM.
A double reciprocal plots of the initial velocity (v)
against DOVA concentration in a series of fixed concen
tration of alanine yielded a set of parallel lines (Fig.l3a).
Similarly, plots of 1/alanine against a 1/v at varying DOVA
generated a series of parallel lines (Fig. 13b). Thus,
Lineweaver Burk plots generated a series of parallel lines
indicating ping-pong reaction mechanism, which is character
istic of transaminases.
Molecular weight determination The elution volume of
alanine:4,5-dioxovalerate transaminase in a calibrated
Sepharose-6B column is as described in Materials and
Methods, corresponds to a apparent molecular weight of
232,000 ~ 3000 (Fig. 14). Disc gel electrophoresis of
the purified enzyme in presence of SDS showed a very
defined single band proving the monomeric nature of the
protein. Migration of transaminase in SDS-polyacrylamide
gel electrophoresis was compared to the migration of the
marker proteins and thereby molecular weight was found
to be approximately 41,000 + 2000 (Fig. 15). These
Fig. 13a Lineweaver-Burk double reciprocal
plots of initial velocity of
alanine:4,5-dioxovalerate transa
minase activity against alanine
concentration at a series of fixed
DOVA concentrations.
8
6 -1-(j')
~ 4 ::>
-1> 2
2 4 6 8
1 10-4 mM ALANINE
10
DOVA 0.~ mM DOVA 0.2 mM DOVA 0.4mM
~
Fig. 13b Lineweaver-Burk double reciprocal
plots of initial velocity of
alanine:4,5-dioxovalerate transa
minase activity against DOVA
concentration at a series of fixed
alanine concentrations.
10
8
6
-1_;, 0\ 4
-E .......
':J --1> 2
2 4 6
1 -3 --10· mM DOVA
ALANINE 1 mM
ALANINE 2mM
ALANINE 4mM
8 10
Fig. 14 Determination of the molecular
weight of purified alanine:
4, 5-dioxovaler·ate transaminase
in native form. Sepharose-6B
(2,0 x 37 em) column was calibrated
with 1 mg of Ferritin (440,000),
2 mg of Thyroglobulin (669,000),
and Aldolase (158,000). 5 mg of
catalase (232,000) and 1 mg of
enzyme was applied.
0.6
0.5
0.4
> 0 0.3 ~
0.2
0.1
L-Ata nine DOVA transaminase ~ o Catalase
o~------~---L-----L----~~-1 00000 500000 1X10
6
LOG MOLECULAR WEIGHT
~ig. 15 Molecular weight determination
of alanine:DOVA transaminase by
SDS-polyacrylamide gel electro
phoresis: 10 pg of each standard
and the enzyme were treated as
described in "Materials and
Methods". Calculation of mobili
ties of protein standards,
electrophoresed simultaneously are
expressed relative to that of
bromophenol blue dye front.
10 5 Phosphorylase b
t-I (!)
w 5 X 104 3 Ovalbumin
0::: L-Alanine DOVA transaminase <{
~
Carbonic anhydrous :::> u w ~
0 2 Xl04 Trypsin inhibitor ~
~ Lactalbumin 0
....J
Rf
- 68 -
results indicate that the rat liver alanine:DOVA
transaminase contains six identical subunits.
Stability The purified enzyme was stable in 50 mM
potassium phosphate buffer, pH 7.6, containing 10% glycerol 0 .
and could be stored at 4 C for at least 1 week without any
significant loss of activity. It is stable at -20°C for
atleast a month without any significant loss o-f its
activity and at -70°C the enzyme was stable for at least
2-3 months. Freezing and thawing did not affect the
enzyme activity significantly. The purified enzyme
is heat stable, but when heated for 30 min at 65°C
lost 88% of its activity (Fig. 16).
Inhibitors of alanine:DOVA transaminase : The effect of
several known inhibitors on alanine:DOVA transaminase were
studied. Among sulfhydryl reactive agents p-chloromercuric
benzene sulfonate was particularly effective inhibitors
at micromolar concentrations. Iodoacetate was effective
inhibitor when employed at millimolar concentrations,
whereas N-ethyl-maleimide was the least effective
inhibitor (Table W\11. The other comp<:mnds viz. pyruvate '•'\i
.the reaction product and substrate analogs i.e • ..c-ketoglutaric
acid,methylglyoxal were also found to be as inhibitors
(Table VII). The enzyme activity was markedly decreased
by the addition of pyridoxal phosphate to the incubation
Fig. 16 : Thermal stability of L-alanine:
DOVA transaminase. The
purified enzyme was maintained
at 65°C for different lengths
of time before assay of the
enzyme.
!
_9.0 c ClJ -0 !.... a. Ol
E
2.s.o >t-
> tu <(
UJ 2 >N z w o~----~----J------L----~------~-
0 10 20 30 40 50
TIME
TABLE VI
EFFECT'OF SULPHYDRYL INHIBITORS ON L-ALANINE: 4,5-DIOXOVALERATE TRANSAMINASE ACTIVITY*
Inhibitor
P-Chloromercuricbenzene sulfonate
N-Ethylmaleimide
Iodoacetate
cocentration ( mH )
0.01 0.02 0.05
0.5 1.0 2.0
0.1 0.5 1.0 2.0
Specific activity pmol ALA formed/mg protein/30 min
1.41
1.07 (24) 0.11 ( 9 2) 0 (100)
1. 37 (3) 1. 33 ( 6) 1.27 ( 11)
1.27 (11) 1.11 ( 31) 0.55 (62) 0.22 (85)
-----------------------------------------------------------Numbers in the parenthesis are percent inhibition.
. .
*The purified enzyme was preincubated at 37°C for 5 min with the inhibitors and the reaction was started immediately by adding substrates. Conditions for the assay were the same as described in the "Materials and Methods".
TABLE VII
INHIBITORS OF L-ALANINE:4,5-DIOXOVALERATE TRANSAMINASE*
Inhibitor
Reaction product Pyruvic acid
Substrate analogs methylglyoxal
oC-ketoglutaric acid
Concentration ( mM }
0.05 0.10 0.25 .0. 50 l.oo· 2.00
0.25 0.50 1.00
5.00 15.00 30.00
Specific activity pmol ALA formed/mg . protein/30 min
1.000
0.912 (9} 0.·821 (18) 0.569 (43) 0.370 (63) 0.192 (81)
( 10 0)
0.613 (39) 0.403 ( 60} . 0.185 (82}
0.833 ( 1 7) 0.759 (24) 0.500 (50)
Numbers in the parenthesis are percent inhibition.
*The purified enzyme was preincubated at 37oc for 5 min with the inhibitors and the reaction was started by additing the substrates. Assay conditions were same as mentioned in "Materials and Methods".
- 69 ...:.
mixture (Table VIII). As it was evident from our studies
excess concentration of dioxovalerate inhibited the enzyme
activity (Table VIII).
Pyridoxal phosphate studies : Pyridoxal phosphate functions
at the active site of a number of enzymes. Usually it is
expected to find this cofactor associated with transaminase.
The homogeneous enzyme preparation appeared to have a pale
yellow colour. The enzyme bound pyridoxal phosphate in
the purified enzyme was 10.6 nmole of PLP/mg of purified
protein. It was not possible to enhance the enzyme
activity by the addition of py-ridoxal phosphate at any
stage during enzyme assay. It supports our observation
that the cofactor is tightly bound.
DISCUSSION
The report describes the purification and properties
of alanine:OOVA transaminase of rat liver mitochondria.
This is the first report on the purification using a new
procedure to apparent homogeneity as demonstrated by
polyacrylamide gel electrophoresis. The DOVA transaminase
was purified 422-fold with a recovery of 20%. The final
enzyme preparation has a specific activity of 59.5 u/mg.
protein.
The initial purification steps, fractionation with
protamine sulfate, which is a polycation, are especially
TABLE VIII
INHIBITION OF L-ALANINE:4,5-DIOXOVALERATE TRANSAMINASE BY PYRIDOXAL PHOSPHATE AND 4,5-DIOXOVALERIC ACID*
-------~-----------------------------------------------------
Inhibitor
Control
PLP
2.5 mM
5.0 mM
DOVA
1.5 ml\'1
2.5 mM
4.0 mM
Specific Activity <p mol./30 min/mg protein)
18.63
4.11 (78)
2.03 (89)
13.91 (29)
11.88 (41)
5.77 (70)
Numbers in the parentheses are percent inhibition.
*The purified enzyme was preincubated at 37°C for 5 min with the inhibitors and the reaction was started by additing the substrates. Assay conditions were same as mentioned in "I>laterials and Methods.
- 70 -
useful in the removal of nucleic acids because of the
large negative charges of such compounds make complex
quite efficient. Bentonite, which is a clay, precipitates
the proteins by adsorption depending on its concentration,
and provided-a 3.7 fold purification with a good recovery.
An improvement in the purification of alanine:DOVA
transaminase was accomplished by exploitation of its
unique hydrophobic properties. The enzyme even in the
presence of high concentration of salt did not bind to the
phenyl sepharose, however, most of other hydrophobic
proteins were bound to this support, the enzyme was eluted
in the buffer wash. The hydrophobic column provided a
significant fold of purification. Further, su-bsequent steps
with DEAE cellulose DE-52 which is an anion exchange
chromatography, Sepharose-6B gel filtration gave a final
homogenous protein with a specific activity of 59.5 u/mg.
protein. The specific ac~ivity is higher than previously
reported values for homogenous liver alanine:DOVA transa
minase (142). During ~&e processes of purification we
have also tried some other procedures to purify the
enzyme from the crude extract. These include ammonium
sulphate pre?ipitation, calcium phosphate gel chromato
graphy and heat denaturation, which are frequently used
for all transaminases purification. Unfortunately none
of these procedures gave satisfactory results and
- 71 -
therefore, have not been included in the purification
scheme.
An overall yield of about 20% of alanine:DOVA
transaminase was obtained from rat liver Mitochondria.
This was significantly greater than that obtained for the
purified enzyme from bovine liver 0.753 units/mg. protein.
The polyacrylamide gel electrophoresis at pH 8.9
(Fig. 9a) confirms the purity of enzyme preparations and
further SDS-PAGE at pH 8.3 suggests (Fig. 15) that the
enzyme is monomeric in nature. The native enzyme of rat
had a molecular weight of 232,000 + 3000 and appeared to
be composed of identical subunits of M 41,000 ::!::_ 2_000 r
daltons. This data indicated that the enzyme was a
homohexamer. The molecular weight suggests that the
enzyme was isolated as an oligomer. Most known transa-
minases have molecular weights approximately 100,000
dal tons.
Alanine:DOVA transaminase has distinct substrate
specificity for both amino donor (L-alanine) and the
amino aceptor (4,5-dioxovalerate). Other amino donors
and aceptors had only a fraction of the reactivity of
these two compounds. None of the alternate amino donors
studied appeared to inhibit the enzyme, whereas the
alternate amino aceptors were inhibitory.
- 72 -
The enzyme had a pH optimum which was similar to
those reported by others (21,142) for bovine liver alanine:
DOVA transaminase.
The Km values found for rat alanine:DOVA transaminase
for alanine was 3.3 mM and 4,5-dioxovaleric acid was
0.28 mM. According to Varticoviski et al. (21) the bovine
liver had the apparent Km values 3.7 m!o!J. for alanine and
0.24 mM for 4,5-dioxovalerate. Whereas, Noguch and
Mori (140) reported Km values of 2.5 mM and 0.3 mM for
alanine and 4,5-dioxovalerate respectively.
A similar property of the rat hepatic alanine:DOVA
transaminase with bovine hepatic enzyme was the pale
yellow colour of the homogeneous preparation. Since a
pyridioxal derivative has been shown to be associated
with the bovine liver DOVA transaminase (21), our
findings further report the a:nount of enzyme bound pyridoxal
phosphate.
The inhibitory effect of sulfhydryl inhibitors, PLP
on the activity of alanine:DOVA transaminase have not
been shown ea~lier in bovine liver enzyme. However, the
inhibitory effect of DOVA being one of the substrates
has been reported in Rhodopseudomonas spheroides (174) ..
Similarly the substrate analogs -ketoglutaric acid and
methylglyoxal, pyrugic acid, a product has been observed
- 73 -
to be inhibitors of alanine:DOVA transaminase.
Therefore, after purification of alanine:DOVA
transaminase to homogeneity, we believe that it will be a
useful system to study the regulatory role of this enzyme
in heme biosynthesis and to examine whether drugs or
inducers of cytochrome P-450 have any effect on this
enzyme activity. In our laboratory, further work is
going on to raise antibody against alanine:DOVA transa
minase in rabbit and by immunotitrating we are planning
to study the role of specific DOVA transaminase in
different erythropoietic conditions or hemeprotein
synthesis to enlighten its role on heme biosynthesis.